SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 80.08 |
| Enterprise Value ($M) | 63.78 |
| Book Value ($M) | 252.95 |
| Book Value / Share | 2.72 |
| Price / Book | 0.32 |
| NCAV ($M) | 159.01 |
| NCAV / Share | 1.71 |
| Price / NCAV | 0.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.43 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.16 |
| Current Ratio | 7.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 219.38 |
| Assets | 313.31 |
| Liabilities | 60.36 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9.99 |
| Operating Income | -162.12 |
| Net Income | -149.10 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -138.20 |
| Cash from Investing | 86.61 |
| Cash from Financing | 16.72 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bank Of America Corp /de/ | 2.20 | -61.35 | |
| 13D/A | Haurwitz Rachel E. | 4.80 | 20.92 | |
| 13G/A | PFM Health Sciences, LP | 4.80 | ||
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 3.00 | -38.88 | |
| 13G/A | Vanguard Group Inc | 5.11 | 0.00 | |
| 13G/A | State Street Corp | 1.80 | -68.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 364,762 | 899,617 | 40.55 | |
| 400,624 | 1,244,747 | 32.19 | |
| 290,352 | 748,217 | 38.81 | |
| 424,100 | 994,080 | 42.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| COGT – Cogent Biosciences, Inc. | COLL – Collegium Pharmaceutical, Inc. |
| CPIX – Cumberland Pharmaceuticals Inc. | CRGX – CARGO Therapeutics, Inc. |
| CRNX – Crinetics Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io